Current preservation technology and future prospects of thoracic organs. Part 2: heart
- PMID: 20125018
- DOI: 10.1097/MOT.0b013e328337343f
Current preservation technology and future prospects of thoracic organs. Part 2: heart
Abstract
Purpose of review: The problem of organ shortage continuously emphasizes the importance of proper donor management and selection, organ preservation and recipient selection and treatment. This review summarizes state of the art of cardiac allograft preservation with special regard to recent clinical and experimental findings.
Recent findings: Over the past years no major strategy changes have found their way to the clinical setting of cardiac allograft preservation. Static, antegrade, cold, crystalloid flush perfusion is still the commonly used technique to preserve the heart. The importance of electrolyte composition, substrates and ischemia/reperfusion injury inhibiting additives are discussed with special attention to recent findings. Machine perfusion during preservation has regained attention over recent years and has led to the first clinical safety and feasibility trials in Europe and the USA.
Summary: No major changes were introduced in the technique of heart preservation over the past years. Many new ideas based upon experimental data were postulated but still have to find their way to the clinical setting.There is a renewed interest in mechanical perfusion. Everyone is curiously awaiting the first clinical reports.
Similar articles
-
Thoracic organs: current preservation technology and future prospects; part 1: lung.Curr Opin Organ Transplant. 2010 Apr;15(2):150-5. doi: 10.1097/MOT.0b013e3283373b7e. Curr Opin Organ Transplant. 2010. PMID: 20125017 Review.
-
Machine perfusion for cardiac allograft preservation.Curr Opin Organ Transplant. 2008 Oct;13(5):526-30. doi: 10.1097/MOT.0b013e32830fdf9a. Curr Opin Organ Transplant. 2008. PMID: 19060537 Review.
-
Ex-vivo normothermic liver perfusion: an update.Curr Opin Organ Transplant. 2010 Apr;15(2):167-72. doi: 10.1097/MOT.0b013e328337349d. Curr Opin Organ Transplant. 2010. PMID: 20186059 Review.
-
Machine perfusion of the liver: past, present and future.Curr Opin Organ Transplant. 2010 Apr;15(2):160-6. doi: 10.1097/MOT.0b013e328337342b. Curr Opin Organ Transplant. 2010. PMID: 20125022 Review.
-
Preservation of the donor heart: from basic science to clinical studies.Interact Cardiovasc Thorac Surg. 2015 Apr;20(4):510-9. doi: 10.1093/icvts/ivu432. Epub 2014 Dec 23. Interact Cardiovasc Thorac Surg. 2015. PMID: 25538253 Review.
Cited by
-
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies.Cardiovasc Res. 2014 Dec 1;104(3):399-411. doi: 10.1093/cvr/cvu225. Epub 2014 Oct 24. Cardiovasc Res. 2014. PMID: 25344369 Free PMC article. Review.
-
Machine perfusion of thoracic organs.J Thorac Dis. 2018 Apr;10(Suppl 8):S910-S923. doi: 10.21037/jtd.2018.02.85. J Thorac Dis. 2018. PMID: 29744218 Free PMC article. Review.
-
Failing Heart Transplants and Rejection-A Cellular Perspective.J Cardiovasc Dev Dis. 2021 Dec 12;8(12):180. doi: 10.3390/jcdd8120180. J Cardiovasc Dev Dis. 2021. PMID: 34940535 Free PMC article. Review.
-
Expansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samples.PLoS One. 2011;6(7):e21778. doi: 10.1371/journal.pone.0021778. Epub 2011 Jul 21. PLoS One. 2011. PMID: 21814552 Free PMC article.
-
Addition of long-distance heart procurement promotes changes in heart transplant waiting list status.Rev Bras Cir Cardiovasc. 2014 Jul-Sep;29(3):344-9. doi: 10.5935/1678-9741.20140046. Rev Bras Cir Cardiovasc. 2014. PMID: 25372907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous